BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Epiphany Biosciences, Inc. 

One California Street
Suite 2800
San Francisco  California  94111  U.S.A.
Phone: 415-765-7193 Fax: 415-765-7200


SEARCH JOBS





Segment
Start Up





 Company News
Medivir AB (MVIRb.F): Epiphany Biosciences, Inc. Announces Positive Results from Its Phase 2b Trial in Shingles 11/19/2009 9:26:44 AM    More...
Epiphany Biosciences, Inc. Announces Positive Results from Its Phase 2b Trial in Shingles 11/18/2009 11:59:26 AM    More...
Epiphany Biosciences, Inc. Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS) 3/24/2009 10:06:23 AM    More...
Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences, Inc. 10/3/2008 11:15:32 AM    More...
Epiphany Biosciences, Inc. to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia 9/9/2008 6:32:59 AM    More...
Epiphany Biosciences, Inc. Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 12/7/2007 6:33:13 AM    More...
Epiphany Biosciences, Inc. Has Initiated Enrollment in Shingles Study with Valomaciclovir (MIV-606, EBP-348) Licensed From Medivir AB (MVIRb.F) 11/8/2007 10:33:50 AM    More...
Epiphany Biosciences, Inc. Reports Initiation and Enrollment in Valomaciclovir Study for Shingles 11/7/2007 7:07:49 AM    More...
Epiphany Biosciences, Inc. Announces Appointments to Its Board of Directors 3/30/2007 12:08:51 PM    More...
Medivir AB (MVIRb.F) Receives Shares and Cash Payment from Epiphany Biosciences, Inc. 3/19/2007 1:07:25 PM    More...
12